Search

Chromanol

Chromanol has been used in trials studying the treatment of Prostate Cancer.

Prolectin-M

[L31343] It is being investigated in the clinical trial NCT04512027 (Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. (Prolectin-M)). … Prolectin-M is a (1-6)-alpha-D-mannopyranose[L31338] and acts as an antagonist of galectin.

Razuprotafib

[L27171,L27176] In investigations against diabetes and COVID-19, razuprotafib is self-administered by patients through subcutaneous injection. … Razuprotafib, also known as AKB-9778, is a small-molecule inhibitor restoring Tie2 activation by inhibiting VE-PTP.

Lanoteplase

Hyaluronic acid (non-animal stabilized)

Hyaluronic acid (non-animal stabilized) is under investigation in clinical trial NCT03460158 (Prospective Evaluation of Facial Cosmetic Procedures).

Glucagon-like peptide II

Glucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome.

Halofuginone

Collgard Biopharmaceuticals is developing halofuginone for the treatment of scleroderma and received orphan drug designation from the U.S. Food and Drug Administration in March, 2000. … Halofuginone also effectively suppresses tumor progression and metastasis in mice.

Veldoreotide

Somatoprim is under investigation for the treatment of Acromegaly.

(S)-AMPA

AMPA is a specific agonist for the AMPA receptor.

3-hydroxyanthranilic acid

An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.